GAL-021 is an investigational small molecule belonging to the histone deacetylase inhibitor class, currently under study for its potential to treat various cancers by modulating epigenetic mechanisms and… Read more
GAL-021 is an investigational small molecule belonging to the histone deacetylase inhibitor class, currently under study for its potential to treat various cancers by modulating epigenetic mechanisms and restoring gene expression in malignant cells. Analytical laboratories involved in pharmaceutical development and quality control require high-quality reference standards of this compound to support critical research and regulatory testing. Our selection includes the parent compound alongside stable isotope-labelled versions, such as GAL-021-d10. These labelled compounds are essential tools for impurity profiling and precise quantitative analysis, particularly in complex matrices like biological samples where they serve as internal standards for mass spectrometry. Utilizing these validated reference materials ensures accuracy and reliability during method development, stability studies, and the monitoring of metabolites throughout the drug development lifecycle.